Boundless Bio (BOLD) Total Liabilities (2023 - 2026)
Boundless Bio (BOLD) posted quarterly Total Liabilities of $54.6 million for Q1 2026, little changed year-over-year from $54.6 million in Q1 2025, and down 6.54% quarter-over-quarter from $58.4 million in Q4 2025.
Boundless Bio (BOLD) Total Liabilities (2023 - 2026) Analysis & Trends
Boundless Bio (BOLD) has reported Total Liabilities for 4 consecutive years, with $54.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Liabilities changed 0.12% year-over-year to $54.6 million; the TTM figure through Mar 2026 stood at $54.6 million (changed 0.12% YoY), while the FY2025 annual figure was $58.4 million, up 4.73% from the prior year.
- Total Liabilities slipped to $54.6 million in Q1 2026 per BOLD's latest filing, from $58.4 million in the prior quarter.
- Across five years, Total Liabilities topped out at $188.2 million in Q2 2024 and bottomed at $9.4 million in Q4 2023.
- Historically, Total Liabilities has averaged $82.8 million across 4 years, with a median of $57.6 million in 2025.
- Annual changes were most pronounced in 2024 — Total Liabilities surged 495.86% — and 2025, when it tumbled 69.84%.
- Boundless Bio's Total Liabilities stood at $9.4 million in 2023, then soared by 495.86% to $55.8 million in 2024, then climbed by 4.73% to $58.4 million in 2025, then declined by 6.54% to $54.6 million in 2026.
- Business Quant data shows BOLD's Total Liabilities at $54.6 million in Q1 2026, $58.4 million in Q4 2025, and $58.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 7.18 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 10.02 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.62 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 4.20 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 4.00 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4.20 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 3.22 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 1.35 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 10.03 Bn |
| 10 | Boundless Bio | 67.35 Mn | 67.35 Mn | - | 7.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.77 Mn |
| Mar 31, 2026 | 54.59 Mn |
| Dec 31, 2025 | 58.41 Mn |
| Sep 30, 2025 | 58.55 Mn |
| Jun 30, 2025 | 56.76 Mn |
| Mar 31, 2025 | 54.65 Mn |
| Dec 31, 2024 | 55.77 Mn |
| Sep 30, 2024 | 175.09 Mn |
| Jun 30, 2024 | 188.20 Mn |
| Mar 31, 2024 | 117.08 Mn |
| Dec 31, 2023 | 9.36 Mn |